Faes Farma, founded in 1933, is a Spanish pharmaceutical company with an extensive international track record that researches, produces and markets pharmaceutical products and raw materials, exporting to numerous countries. The new pharmaceutical production plant of more than 50,000m2 is located in the Derio Technology Park (Bizkaia) and is equipped with all the most innovative technical advances. It is in addition to the existing plant in Leioa, and has the capacity to manufacture more than 100 million units of medicines, which will allow it to significantly increase its current production capacity. The planned expansion in sales will be sustained both geographically and in terms of the launch of new products in the innovation portfolio.
Faes Farma's new state-of-the-art laboratories have a surface area of more than 3,000 m2, with two areas equipped with the most advanced technologies. The entire laboratory area has been equipped by Burdinola, both the quality control laboratories -and their corresponding gas chromatography rooms, dissolution, balances, HPLC, washing areas, storage, etc- and the microbiology laboratories. Safety is our guideline throughout the entire process of setting up the laboratories: from the preliminary study and identification of risks, the design of the spaces, the configuration of the workstations to the equipment and installation. The new laboratories have been equipped with our own designed and manufactured furniture and fume cupboards under the strictest international standards.
The pharmaceutical sector is a highly specialised sector where laboratories have a high level of demand in all parameters and where Burdinola is consolidated as a specialist providing solutions for the complete functional integration of people, spaces, processes and equipment. At Burdinola we combine our manufacturing spirit and our project management capacity to offer the best service to our clients. Our success lies in understanding the needs of the researcher and the application of our knowledge and experience in laboratory design.
With this new project, Burdinola further consolidates its position in the pharmaceutical industry, which is one of the largest and most important in the world and the world leader in R&D investment.